Co-clinical FDG-PET Radiomic Signature in Predicting Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
Sudipta Singha Roy, Timothy Whitehead, Shunqiang Li, Foluso Olabisi Ademuyiwa, Richard L. Wahl, Farrokh Dehdashti, Kooresh Isaac Shoghi
The paper develops radiomic signatures from FDG-PET imaging to predict response to neoadjuvant chemotherapy in triple-negative breast cancer using machine learning in a co-clinical trial setting.
European Journal of Nuclear Medicine and Molecular Imaging · Jul 30, 2021Peer-reviewedBioinformatics